Lanreotide (subcutaneous injection) for treating unresectable locally advanced or metastatic, non-progressive gastroenteropancreatic tumours [ID961]

Draft scope documents

• Draft scope (post-referral) (PDF 114 KB)

  Published:

  04 February 2016

• Provisional matrix (post-referral) (PDF 100 KB)

  Published:

  04 February 2016